Complement and Renal Thrombotic Microangiopathy Associated With Hypertension and Scleroderma

Timmermans, 2017, Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities, Kidney Int, 91, 1420, 10.1016/j.kint.2016.12.009 Heptinstall, 1954, Renal biopsies in hypertension, Br Heart J, 16, 133, 10.1136/hrt.16.2.133 Churg, 1961, Some aspects of the pathology of hypertension. Vascular lesions in experimental and human hypertension, J Mt Sinai Hosp N Y, 28, 111 Chang, 2017, Thrombotic microangiopathy and the kidney, Diagn Histopathol, 23, 101, 10.1016/j.mpdhp.2017.03.006 Ricklin, 2016, Complement in disease: a defence system turning offensive, Nat Rev Nephrol, 12, 383, 10.1038/nrneph.2016.70 Noris, 2010, Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype, Clin J Am Soc Nephrol, 5, 1844, 10.2215/CJN.02210310 González, 2010, Long-term renal survival in malignant hypertension, Nephrol Dial Transpl, 25, 3266, 10.1093/ndt/gfq143 Van Den Born, 2005, Microangiopathic hemolysis and renal failure in malignant hypertension, Hypertension, 45, 246, 10.1161/01.HYP.0000151620.17905.ee Yu, 2014, Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China, Sci World J, 2014, 608502, 10.1155/2014/680502 Zhang, 2008, Renal thrombotic microangiopathies induced by severe hypertension, Hypertens Res, 31, 479, 10.1291/hypres.31.479 Cavero, 2019, Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome, Kidney Int, 96, 995, 10.1016/j.kint.2019.05.014 Geerdink, 2012, Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics, Pediatr Nephrol, 27, 1283, 10.1007/s00467-012-2131-y Totina, 2013, Atypical hemolytic-uremic syndrome in a child presenting with malignant hypertension, Clin Pediatr, 52, 183, 10.1177/0009922811412942 Asif, 2017, Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab, J Nephrol, 30, 347, 10.1007/s40620-016-0357-7 Timmermans, 2018, C5b9 formation on endothelial cells reflects complement defects among patients with renal thrombotic microangiopathy and severe hypertension, J Am Soc Nephrol, 29, 2234, 10.1681/ASN.2018020184 Noris, 2014, Dynamics of complement activation in aHUS and how to monitor eculizumab therapy, Blood, 124, 1715, 10.1182/blood-2014-02-558296 Larsen, 2018, Genetic testing of complement and coagulation pathways in patients with severe hypertension and renal microangiopathy, Mod Pathol, 31, 488, 10.1038/modpathol.2017.154 Amraoui, 2012, Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study, BMC Nephrol, 13, 71, 10.1186/1471-2369-13-71 Rodríguez De Córdoba, 2014, Genetics of atypical hemolytic uremic syndrome (aHUS), Semin Thromb Hemost, 40, 422, 10.1055/s-0034-1375296 Batal, 2009, Renal biopsy findings predicting outcome in scleroderma renal crisis, Hum Pathol, 40, 332, 10.1016/j.humpath.2008.08.001 Okrój, 2016, Analysis of complement biomarkers in systemic sclerosis indicates a distinct pattern in scleroderma renal crisis, Arthritis Res Ther, 18, 1, 10.1186/s13075-016-1168-x Tsai, 2016, Does anticomplement therapy have a role in the management of malignant hypertension?, J Clin Hypertens, 18, 359, 10.1111/jch.12664 Ruderman, 2017, The perfect storm, Kidney Int, 92, 267, 10.1016/j.kint.2017.03.049 Woodworth, 2016, Scleroderma renal crisis and renal involvement in systemic sclerosis, Nat Rev Nephrol, 12, 678, 10.1038/nrneph.2016.124 Hudson, 2007, Hypocomplementemia in systemic sclerosis - clinical and serological correlations, J Rheumatol, 34, 2218 Scambi, 2015, The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating study, PLoS One, 10, 1, 10.1371/journal.pone.0114856 Thomas, 2015, Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome, Clin Kidney J, 8, 698, 10.1093/ckj/sfv101 Osthoff, 2019, Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study, Arthritis Res Ther, 21, 1, 10.1186/s13075-019-1859-1 Uriarte, 2018, Scleroderma renal crisis debute with thrombotic microangiopathy: a successful case treated with eculizumab, Case Rep Nephrol, 2018, 1, 10.1155/2018/6051083 Devresse, 2016, Complement activation and effect of eculizumab in scleroderma renal crisis, Med, 95, 7 Cavero, 2017, Eculizumab in secondary atypical haemolytic uraemic syndrome, Nephrol Dial Transpl, 32, 466, 10.1093/ndt/gfw453